Suggested links

Mesothelioma Treatment by State

It can take up to 50 years to develop mesothelioma after asbestos exposure, which means there are thousands of people across the United States being diagnosed each year who need treatment. These patients can find help from specialized doctors at top cancer centers and hospitals throughout the nation. Learn more about mesothelioma treatment by state below.

Fact-Checked and Updated by: Jenna Tozzi, RN

Last updated:

How Do I Find Mesothelioma Treatment Near Me?

If you’ve been diagnosed with mesothelioma, you and your family may be wondering where you can get the best treatment. Fortunately, there are many cancer centers across the country with doctors who specialize in mesothelioma. These doctors can develop a custom treatment plan based on your individual needs and diagnosis.

Your treatment plan may include a combination of chemotherapy, surgery, and other therapies. You may also be able to access new treatments through clinical trials.

The first step to receiving the right treatment is to make an appointment with a mesothelioma specialist.

We can help you connect with local mesothelioma doctors regardless of where you live. Try our Free Doctor Match now.

Mesothelioma doctor talking with an older couple
Free Mesothelioma Doctor Match

We'll help you connect with a local mesothelioma specialist for personalized treatment.

Find a Doctor Near You

Top States for Mesothelioma Treatment

From Moffitt Cancer Center in Tampa to UCLA Medical Center in Los Angeles, there are a number of mesothelioma treatment centers across the country that can provide patients with specialized cancer care.

Some of the best mesothelioma cancer centers are located in:

If you or a loved one is researching mesothelioma cancer centers, try looking for hospitals that have been recognized by the National Cancer Institute (NCI). This indicates that the facility has met strict criteria for conducting advanced cancer research aimed at finding better ways to prevent, diagnose, and treat mesothelioma.

All of the states listed above are home to at least one NCI-designated cancer center.

Mesothelioma Treatment Options

Pursuing treatment at a mesothelioma center is critical to improving your overall prognosis and life expectancy.

Did You Know?

Pleural mesothelioma patients who receive standard treatments have higher survival rates than patients who go untreated, according to a 2023 report published in the journal Cancer Medicine.

Standard mesothelioma treatment options include:

  • Surgery: Malignant mesothelioma patients may be eligible for tumor-removing surgeries as well as minor outpatient procedures that can help relieve swelling, chest pain, and other painful symptoms.
  • Chemotherapy: Powerful chemotherapy medications administered orally or intravenously target and kill mesothelioma cancer cells throughout the body.
  • Radiation therapy: High-energy radiation is delivered directly to areas with mesothelioma tumors, destroying cancer cells while minimizing damage to healthy tissues.

Mesothelioma cancer centers also offer emerging treatments such as immunotherapy that are being tested in clinical trials and showing improvements in overall survival for some mesothelioma patients. Immunotherapy drugs work by activating the body’s immune response to target and destroy cancer cells.

A 2021 clinical trial led by researchers at MD Anderson Cancer Center found that 40% of peritoneal mesothelioma patients achieved complete or partial remission after being treated with the immunotherapy medications atezolizumab (TECENTRIQ®) and bevacizumab (Avastin®).

Make sure to ask your specialist which treatment options are best for your stage and type of mesothelioma. Download our Free Checklist of Questions to Ask Your Doctor before your next appointment so you leave with the answers you need.

14 Questions to Ask Your Doctor packet
Free Download: 14 Questions to Ask Your Doctor
  • Preparing for treatment
  • Finding clinical trials
  • Getting a second opinion

Get Your Free Download

Locate Mesothelioma Clinical Trials Near You

Clinical trials for mesothelioma are available in some states. Mesothelioma Hope maintains an up-to-date list of ongoing clinical trials categorized by location.

Use our search tool below to see if there are any active mesothelioma clinical trials in your area and get help enrolling.

Active Mesothelioma Clinical Trials (66)Show trials only in:
Clinical Trial for Pleural Biphasic Mesothelioma from Alliance for Clinical Trials in Oncology
Location: Kingman, Arizona (multiple locations)
Call (866) 608-8933 to get help enrolling in this clinical trial
Clinical Trial for Pleural Biphasic Mesothelioma from Alliance for Clinical Trials in Oncology

Our Patient Advocates can help you connect with clinical trials

Call (866) 608-8933 to get started

Trial Name
Official Title Neoadjuvant Immunotherapy in Sarcomatoid Mesothelioma

Conditions
  • Pleural Biphasic Mesothelioma
Interventions
  • Biological: Nivolumab
  • Biological: Ipilimumab
  • Procedure: Surgical Procedure
  • Procedure: Computed Tomography
  • Procedure: Magnetic Resonance Imaging
  • Procedure: Positron Emission Tomography
Facility
  • Kingman Regional Medical Center, Kingman, Arizona
  • Mayo Clinic Hospital in Arizona, Phoenix, Arizona
  • Mayo Clinic in Arizona, Scottsdale, Arizona
  • PCR Oncology, Arroyo Grande, California
  • Beebe South Coastal Health Campus, Frankford, Delaware
  • Beebe Medical Center, Lewes, Delaware
  • Delaware Clinical and Laboratory Physicians PA, Newark, Delaware
  • Helen F Graham Cancer Center, Newark, Delaware
  • Medical Oncology Hematology Consultants PA, Newark, Delaware
  • Christiana Care Health System-Christiana Hospital, Newark, Delaware
  • Beebe Health Campus, Rehoboth Beach, Delaware
  • Christiana Care Health System-Wilmington Hospital, Wilmington, Delaware
  • Mayo Clinic in Florida, Jacksonville, Florida
  • Rush - Copley Medical Center, Aurora, Illinois
  • Northwestern University, Chicago, Illinois
  • University of Chicago Comprehensive Cancer Center, Chicago, Illinois
  • Carle at The Riverfront, Danville, Illinois
  • Northwestern Medicine Cancer Center Kishwaukee, DeKalb, Illinois
  • Carle Physician Group-Effingham, Effingham, Illinois
  • Northwestern Medicine Cancer Center Delnor, Geneva, Illinois
  • Northwestern Medicine Glenview Outpatient Center, Glenview, Illinois
  • Northwestern Medicine Grayslake Outpatient Center, Grayslake, Illinois
  • Northwestern Medicine Lake Forest Hospital, Lake Forest, Illinois
  • Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois
  • Northwestern Medicine Orland Park, Orland Park, Illinois
  • Carle Cancer Center, Urbana, Illinois
  • Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois
  • Rush-Copley Healthcare Center, Yorkville, Illinois
  • Christiana Care - Union Hospital, Elkton, Maryland
  • Mayo Clinic in Rochester, Rochester, Minnesota
  • Carson Tahoe Regional Medical Center, Carson City, Nevada
  • Cancer and Blood Specialists-Henderson, Henderson, Nevada
  • Comprehensive Cancer Centers of Nevada - Henderson, Henderson, Nevada
  • Comprehensive Cancer Centers of Nevada-Horizon Ridge, Henderson, Nevada
  • Las Vegas Cancer Center-Henderson, Henderson, Nevada
  • OptumCare Cancer Care at Seven Hills, Henderson, Nevada
  • Comprehensive Cancer Centers of Nevada-Southeast Henderson, Henderson, Nevada
  • GenesisCare USA - Henderson, Henderson, Nevada
  • Las Vegas Urology - Green Valley, Henderson, Nevada
  • Las Vegas Urology - Pebble, Henderson, Nevada
  • Urology Specialists of Nevada - Green Valley, Henderson, Nevada
  • Las Vegas Urology - Pecos, Las Vegas, Nevada
  • OptumCare Cancer Care at Charleston, Las Vegas, Nevada
  • University Medical Center of Southern Nevada, Las Vegas, Nevada
  • Hope Cancer Care of Nevada, Las Vegas, Nevada
  • Radiation Oncology Centers of Nevada Central, Las Vegas, Nevada
  • Urology Specialists of Nevada - Central, Las Vegas, Nevada
  • GenesisCare USA - Las Vegas, Las Vegas, Nevada
  • Sunrise Hospital and Medical Center, Las Vegas, Nevada
  • Las Vegas Prostate Cancer Center, Las Vegas, Nevada
  • Las Vegas Urology - Sunset, Las Vegas, Nevada
  • Urology Specialists of Nevada - Southwest, Las Vegas, Nevada
  • Radiation Oncology Centers of Nevada Southeast, Las Vegas, Nevada
  • Ann M Wierman MD LTD, Las Vegas, Nevada
  • Comprehensive Cancer Centers of Nevada - Northwest, Las Vegas, Nevada
  • GenesisCare USA - Vegas Tenaya, Las Vegas, Nevada
  • Las Vegas Urology - Cathedral Rock, Las Vegas, Nevada
  • Las Vegas Urology - Smoke Ranch, Las Vegas, Nevada
  • OptumCare Cancer Care at MountainView, Las Vegas, Nevada
  • Urology Specialists of Nevada - Northwest, Las Vegas, Nevada
  • Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada
  • Comprehensive Cancer Centers of Nevada - Town Center, Las Vegas, Nevada
  • Comprehensive Cancer Centers of Nevada-Summerlin, Las Vegas, Nevada
  • Summerlin Hospital Medical Center, Las Vegas, Nevada
  • Las Vegas Cancer Center-Medical Center, Las Vegas, Nevada
  • Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada
  • GenesisCare USA - Fort Apache, Las Vegas, Nevada
  • OptumCare Cancer Care at Fort Apache, Las Vegas, Nevada
  • Comprehensive Cancer Centers of Nevada - Central Valley, Las Vegas, Nevada
  • University Cancer Center, Las Vegas, Nevada
  • Hope Cancer Care of Nevada-Pahrump, Pahrump, Nevada
  • Renown Regional Medical Center, Reno, Nevada
  • Saint Mary's Regional Medical Center, Reno, Nevada
  • Radiation Oncology Associates, Reno, Nevada
  • Duke University Medical Center, Durham, North Carolina
  • Christiana Care Health System-Concord Health Center, Chadds Ford, Pennsylvania
  • Overlake Medical Center, Bellevue, Washington
  • Valley Medical Center, Renton, Washington
  • North Star Lodge Cancer Center at Yakima Valley Memorial Hospital, Yakima, Washington
Clinical Trial for Ovarian Cancer from ProfoundBio US Co.
Location: Los Angeles, California (multiple locations)
Call (866) 608-8933 to get help enrolling in this clinical trial
Clinical Trial for Ovarian Cancer from ProfoundBio US Co.

Our Patient Advocates can help you connect with clinical trials

Call (866) 608-8933 to get started

Trial Name
Phase 1/2 Study of PRO1184 in Patients With Locally Advanced and/or Metastatic Solid Tumors

Conditions
  • Primary Peritoneal Carcinoma
  • Non-small Cell Lung Cancer
  • Mesothelioma
Interventions
  • Drug: PRO1184
Facility
  • University of California Los Angeles Medical Center, Los Angeles, California
  • University of California, San Diego; Moores Cancer Center, San Diego, California
  • USOR Sansum Clinic, Santa Barbara, California
  • Providence Medical Foundation, Santa Rosa, California
  • University of Kansas Medical Center (KUMC), Westwood, Kansas
  • Massachusetts General Hospital, Boston, Massachusetts
  • Dana Farber Cancer Institute, Boston, Massachusetts
  • Karmanos Cancer Institute, Detroit, Michigan
  • START Midwest, Grand Rapids, Michigan
  • University of Oklahoma - Health Sciences Center, Oklahoma City, Oklahoma
  • Sarah Cannon Research Institute at Tennessee Oncology, Nashville, Tennessee
  • USOR Texas Oncology, Abilene, Texas
  • Mary Crowley Cancer Research, Dallas, Texas
  • USOR Texas Oncology, Fort Worth, Texas
  • START Mountain Region, West Valley City, Utah
  • USOR Virginia Cancer Specialists, Fairfax, Virginia
Clinical Trial for Pleural Effusion, Malignant from Travera Inc
Location: Oakland, California
Call (866) 608-8933 to get help enrolling in this clinical trial
Clinical Trial for Pleural Effusion, Malignant from Travera Inc

Our Patient Advocates can help you connect with clinical trials

Call (866) 608-8933 to get started

Trial Name
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance

Conditions
  • Pleural Effusion, Malignant
  • Ascites, Malignant
  • Mesothelioma
Facility
  • xCures, Oakland, California
Clinical Trial for CD30-Positive Neoplastic Cells Present from M.D. Anderson Cancer Center
Location: Houston, Texas
Call (866) 608-8933 to get help enrolling in this clinical trial
Clinical Trial for CD30-Positive Neoplastic Cells Present from M.D. Anderson Cancer Center

Our Patient Advocates can help you connect with clinical trials

Call (866) 608-8933 to get started

Trial Name
Phase II Trial of Adcetris (Brentuximab Vedotin) in CD30+ Malignant Mesothelioma

Conditions
  • Malignant Mesothelioma
Interventions
  • Drug: Brentuximab Vedotin
  • Other: Laboratory Biomarker Analysis
Facility
  • M D Anderson Cancer Center, Houston, Texas
Clinical Trial for Malignant Peritoneal Mesothelioma from Memorial Sloan Kettering Cancer Center
Location: Chicago, Illinois (multiple locations)
Call (866) 608-8933 to get help enrolling in this clinical trial
Clinical Trial for Malignant Peritoneal Mesothelioma from Memorial Sloan Kettering Cancer Center

Our Patient Advocates can help you connect with clinical trials

Call (866) 608-8933 to get started

Trial Name
ICARuS II (Intraperitoneal Chemotherapy After cytoReductive Surgery): A Multicenter, Randomized Phase II Trial of Normothermic Intraperitoneal Chemotherapy and Intravenous Chemotherapy After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma

Conditions
  • Peritoneal Mesothelioma
  • Mesothelioma
  • Mesothelioma, Malignant
  • Malignant Mesothelioma
Interventions
  • Drug: Pemetrexed
  • Drug: Cisplatin
  • Drug: Carboplatin
Facility
  • University of Chicago (Data Collection Only), Chicago, Illinois
  • University of Nebraska (Data collection only), Omaha, Nebraska
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey
  • Rutgers University (Data Collection Only), New Brunswick, New Jersey
  • Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack, New York
  • Memorial Sloan Kettering Westchester (Limited Protocol Activites), Harrison, New York
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York
  • Allegheny Health Network (Data Collection Only), Pittsburgh, Pennsylvania
Clinical Trial for Peritoneal Carcinomatosis from National Institutes of Health Clinical Center (CC)
Location: Bethesda, Maryland
Call (866) 608-8933 to get help enrolling in this clinical trial
Clinical Trial for Peritoneal Carcinomatosis from National Institutes of Health Clinical Center (CC)

Our Patient Advocates can help you connect with clinical trials

Call (866) 608-8933 to get started

Trial Name
Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies

Conditions
  • Peritoneal Carcinomatosis
  • Peritoneal Mesothelioma
Interventions
  • Procedure: Heated Intraperitonial Chemotherapy
  • Drug: Oxaliplatin
  • Drug: 5-Fluorouracil
Facility
  • National Institutes of Health Clinical Center, Bethesda, Maryland
Clinical Trial for Non Small Cell Lung Cancer from Molecular Templates, Inc.
Location: Los Angeles, California (multiple locations)
Call (866) 608-8933 to get help enrolling in this clinical trial
Clinical Trial for Non Small Cell Lung Cancer from Molecular Templates, Inc.

Our Patient Advocates can help you connect with clinical trials

Call (866) 608-8933 to get started

Trial Name
A Phase 1 Open-label, Multicenter, Dose-ranging Study to Investigate Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types

Conditions
  • Non Small Cell Lung Cancer
  • Mesothelioma
Interventions
  • Drug: MT-8421
Facility
  • The Angeles Clinic, Los Angeles, California
  • Horizon Oncology Research, LLC, Lafayette, Indiana
  • Washington University in St. Louis, Saint Louis, Missouri
  • Weill Cornell Medicine, New York, New York
  • NEXT Oncology, Fairfax, Virginia
Clinical Trial for Ovarian Cancer, Epithelial from Nurix Therapeutics, Inc.
Location: Duarte, California (multiple locations)
Call (866) 608-8933 to get help enrolling in this clinical trial
Clinical Trial for Ovarian Cancer, Epithelial from Nurix Therapeutics, Inc.

Our Patient Advocates can help you connect with clinical trials

Call (866) 608-8933 to get started

Trial Name
A Phase 1a, Dose Escalation, Safety and Tolerability Study of NX-1607, a Casitas B-lineage Lymphoma Proto-oncogene (CBL-B) Inhibitor, in Adults With Advanced Malignancies, With Phase 1b Expansion in Select Tumor Types

Conditions
  • Malignant Pleural Mesothelioma (MPM)
Interventions
  • Drug: NX-1607
Facility
  • City of Hope, Duarte, California
  • University of Southern California, Los Angeles, California
  • University of California, San Francisco, San Francisco, California
  • University of Colorado School of Medicine, Aurora, Colorado
  • University of Chicago, Chicago, Illinois
  • Memorial Sloan Kettering Cancer Center, New York, New York
  • University of North Carolina, Chapel Hill, North Carolina
  • University of Oklahoma, Oklahoma City, Oklahoma
  • MD Anderson Cancer Center, Houston, Texas
  • University of Virginia, Charlottesville, Virginia
  • Swedish Cancer Institute, Seattle, Washington
  • Fred Hutchinson Cancer Center, Seattle, Washington
Clinical Trial for Pancreatic Cancer from NGM Biopharmaceuticals, Inc
Location: Gilbert, Arizona (multiple locations)
Call (866) 608-8933 to get help enrolling in this clinical trial
Clinical Trial for Pancreatic Cancer from NGM Biopharmaceuticals, Inc

Our Patient Advocates can help you connect with clinical trials

Call (866) 608-8933 to get started

Trial Name
A Phase 1 Dose Escalation/Dose Finding Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

Conditions
  • Non-small Cell Lung Cancer
  • Mesothelioma
Interventions
  • Drug: NGM831
Facility
  • NGM Clinical Study Site, Gilbert, Arizona
  • NGM Clinical Study Site, Los Angeles, California
  • NGM Clinical Study Site, Sarasota, Florida
  • NGM Clinical Study Site, Tampa, Florida
  • NGM Clinical Study Site, Grand Rapids, Michigan
  • NGM Clinical Study Site, New York, New York
  • NGM Clinical Study Site, Oklahoma City, Oklahoma
  • NGM Clinical Study Site, Austin, Texas
  • NGM Clinical Study Site, Houston, Texas
Clinical Trial for Triple Negative Breast Cancer from A&G Pharmaceutical Inc.
Location: Baltimore, Maryland
Call (866) 608-8933 to get help enrolling in this clinical trial
Clinical Trial for Triple Negative Breast Cancer from A&G Pharmaceutical Inc.

Our Patient Advocates can help you connect with clinical trials

Call (866) 608-8933 to get started

Trial Name
FIH Phase 1A /1B Study of AG01 Antibody Against Progranulin/GP88 in Advanced Solid Tumor Malignancies With Expansion Cohorts in Advanced Triple Negative Breast Ca, Hormone Resistant Breast Ca, Non Small Cell Lung Cancer and Mesothelioma

Conditions
  • Non Small Cell Lung Cancer
  • Mesothelioma
Interventions
  • Drug: AG-01 Compound
Facility
  • University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland
Clinical Trial for Locally Advanced Solid Tumor from Tango Therapeutics, Inc.
Location: Palo Alto, California (multiple locations)
Call (866) 608-8933 to get help enrolling in this clinical trial
Clinical Trial for Locally Advanced Solid Tumor from Tango Therapeutics, Inc.

Our Patient Advocates can help you connect with clinical trials

Call (866) 608-8933 to get started

Trial Name
A Phase 1/2, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Anti-tumor Activity of TNG462 in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors

Conditions
    Interventions
    • Drug: TNG462
    Facility
    • Stanford University, Palo Alto, California
    • Sylvester Comprehensive Cancer Center, Miami, Florida
    • Dana Farber Cancer Institute, Boston, Massachusetts
    • New York University Langone Health, New York, New York
    • Sarah Cannon Tennessee Oncology, Nashville, Tennessee
    • The University of Texas MD Anderson Cancer Center, Houston, Texas
    • Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah
    Clinical Trial for Cutaneous Melanoma from Seagen Inc.
    Location: Los Angeles, California (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Cutaneous Melanoma from Seagen Inc.

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    A Phase 1 Study of SGN-BB228 in Advanced Melanoma and Other Solid Tumors

    Conditions
    • Non-small Cell Lung Cancer
    • Mesothelioma
    Interventions
    • Drug: SGN-BB228
    Facility
    • University of California Los Angeles Medical Center, Los Angeles, California
    • University of California, San Francisco | HDFCCC - Hematopoietic Malignancies, San Francisco, California
    • Sarah Cannon Research Institute at HealthONE - Denver, Denver, Colorado
    • Northwestern University, Chicago, Illinois
    • University of Iowa Hospitals and Clinics, Iowa City, Iowa
    • Massachusetts General Hospital, Boston, Massachusetts
    • Dana Farber Cancer Institute, Boston, Massachusetts
    • NYU Langone Hospital, New York, New York
    • Duke University Medical Center, Durham, North Carolina
    • Texas Oncology - Baylor Sammons Cancer Center, Dallas, Texas
    • Fred Hutchinson Cancer Center / Seattle Cancer Care Alliance / University of Washington, Seattle, Washington
    Clinical Trial for Advanced Solid Tumor from Constellation Pharmaceuticals
    Location: Atlanta, Georgia (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Advanced Solid Tumor from Constellation Pharmaceuticals

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    A Phase 1/2 Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas

    Conditions
    • Mesothelioma, Malignant
    Interventions
    • Drug: CPI-0209
    Facility
    • Winship Cancer Institute of Emory University, Atlanta, Georgia
    • University of Chicago Medical Center, Chicago, Illinois
    • University of Maryland - Marlene and Stewart Greenebaum Cancer Center, Baltimore, Maryland
    • Massachusetts General Hospital, Boston, Massachusetts
    • Dana Farber Cancer Institute, Boston, Massachusetts
    • University of Michigan Hospital, Ann Arbor, Michigan
    • South Texas Accelerated Research Therapeutics (Start) - Midwest Location, Grand Rapids, Michigan
    • Hackensack University Medical Center, Hackensack, New Jersey
    • Montefiore Einstein Center for Cancer Care, Bronx, New York
    • NYU Langone Medical Center - Laura and Isaac Perlmutter Cancer Center, New York, New York
    • Weill Medical College of Cornell University, New York, New York
    • University of Cincinnati Medical Center, Cincinnati, Ohio
    • South Texas Accelerated Research Therapeutics, San Antonio, Texas
    • University of Virginia Health System, Charlottesville, Virginia
    • Swedish Cancer Institute, Seattle, Washington
    • Fred Hutchinson Cancer, Seattle, Washington
    Clinical Trial for Malignant Abdominal Neoplasm from Mayo Clinic
    Location: Rochester, Minnesota
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Malignant Abdominal Neoplasm from Mayo Clinic

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    A Prospective Study of Heated Intra-Peritoneal Chemotherapy (H.I.P.E.C.) With Doxorubicin and Cisplatin in Pediatric Patients With Pelvic and Abdominal Tumors. The TOAST IT Trial (Trial Of Adjuvant Surgical Treatment With Intraperitoneal Chemotherapy)

    Conditions
    • Recurrent Malignant Mesothelioma
    • Recurrent Primary Peritoneal Carcinoma
    • Refractory Malignant Mesothelioma
    • Resectable Malignant Mesothelioma
    • Resectable Sarcoma
    Interventions
    • Drug: Cisplatin
    • Procedure: Cytoreductive Surgery
    • Drug: Doxorubicin
    • Drug: Hyperthermic Intraperitoneal Chemotherapy
    • Drug: Sodium Thiosulfate
    • Procedure: Computed Tomography
    • Procedure: Magnetic Resonance Imaging
    • Procedure: Positron Emission Tomography
    • Procedure: Biospecimen Collection
    Facility
    • Mayo Clinic in Rochester, Rochester, Minnesota
    Clinical Trial for Pleural Mesothelioma from University of Chicago
    Location: Chicago, Illinois
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Pleural Mesothelioma from University of Chicago

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    A Pilot Window-of-opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural Mesothelioma

    Conditions
    • Pleural Mesothelioma
    Interventions
    • Drug: Pembrolizumab
    • Drug: Cisplatin and Pemetrexed
    Facility
    • University of Chicago, Chicago, Illinois
    Clinical Trial for Malignant Pleural Mesothelioma from Memorial Sloan Kettering Cancer Center
    Location: Basking Ridge, New Jersey (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Malignant Pleural Mesothelioma from Memorial Sloan Kettering Cancer Center

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    Phase I Dose Escalation and Local Control Study of Pembrolizumab + Intensity-Modulated Pleural Radiation Therapy (IMPRINT) for Malignant Pleural Mesothelioma

    Conditions
    • Malignant Pleural Mesothelioma
    Interventions
    • Drug: Pembrolizumab
    • Radiation: IMPRINT
    Facility
    • Memorial Sloan Kettering Basking Ridge (Limited protocol activities), Basking Ridge, New Jersey
    • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey
    • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey
    • Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack, New York
    • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York
    • Memorial Sloan Kettering Cancer Center, New York, New York
    • Memorial Sloan Kettering Nassau (Limited protocol activities), Rockville Centre, New York
    Clinical Trial for Mesothelioma from National Institutes of Health Clinical Center (CC)
    Location: Bethesda, Maryland
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Mesothelioma from National Institutes of Health Clinical Center (CC)

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma and Other Mesothelin Expressing Cancers

    Conditions
    • Mesothelioma
    Facility
    • National Institutes of Health Clinical Center, Bethesda, Maryland
    Clinical Trial for Advanced Cancer from Merck Sharp & Dohme LLC
    Location: New Brunswick, New Jersey (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Advanced Cancer from Merck Sharp & Dohme LLC

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects With Advanced Solid Tumors (KEYNOTE 158)

    Conditions
    • Small Cell Lung Carcinoma
    • Small Cell Lung Cancer (SCLC)
    • Mesothelioma
    Interventions
    • Biological: pembrolizumab
    Facility
    • Call for Information (Investigational Site 0008), New Brunswick, New Jersey
    Clinical Trial for Peritoneal Metastases from Lumicell, Inc.
    Location: Boston, Massachusetts
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Peritoneal Metastases from Lumicell, Inc.

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    Feasibility of the LUM Imaging System for Detection of Peritoneal Surface Malignancies

    Conditions
    • Peritoneal Metastases
    Interventions
    • Combination Product: LUM Imaging System
    Facility
    • Massachusetts General Hospital, Boston, Massachusetts
    Clinical Trial for Mesothelioma from Novartis
    Location: Chicago, Illinois (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Mesothelioma from Novartis

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    An Open-label, Multi-center, Phase I Study of Oral IAG933 in Adult Patients With Advanced Mesothelioma and Other Solid Tumors

    Conditions
    • Mesothelioma
    Interventions
    • Drug: IAG933
    Facility
    • Uni of Chi Medi Ctr Hema and Onco Main Centre, Chicago, Illinois
    • Massachusetts General Hospital Massachusetts General Hospital, Boston, Massachusetts
    • Cleveland Clinic Foundation ., Cleveland, Ohio
    • MD Anderson Cancer Center, Houston, Texas
    Clinical Trial for Lung Non-Small Cell Carcinoma from Roswell Park Cancer Institute
    Location: Buffalo, New York
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Lung Non-Small Cell Carcinoma from Roswell Park Cancer Institute

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    Utilizing Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-Small Cell Lung Cancer (NSCLC) With Pleural Disease or Malignant Pleural Mesothelioma (MPM) - Phase I Study

    Conditions
    • Pleural Disorder
    Interventions
    • Drug: Porfimer Sodium
    • Procedure: Video-Assisted Thoracic Surgery
    • Drug: Photodynamic Therapy
    • Device: Intraoperative PDT
    Facility
    • Roswell Park Cancer Institute, Buffalo, New York
    Clinical Trial for Carcinoma, Non-Small-Cell Lung from Novartis
    Location: Boston, Massachusetts (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Carcinoma, Non-Small-Cell Lung from Novartis

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    A Phase I, Open-label, Multi-center Study of KFA115 as a Single Agent and in Combination With Pembrolizumab in Patients With Select Advanced Cancers

    Conditions
    • Mesothelioma
    Interventions
    • Drug: KFA115
    Facility
    • Massachusetts General Hospital ., Boston, Massachusetts
    • NYU School of Medicine Langone Health, New York, New York
    • University of Pittsburgh MC, Pittsburgh, Pennsylvania
    • SCRI Oncology Partners Sarah Cannon new location, Nashville, Tennessee
    Clinical Trial for Mesothelioma from Dana-Farber Cancer Institute
    Location: Boston, Massachusetts
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Mesothelioma from Dana-Farber Cancer Institute

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers

    Conditions
    • Mesothelioma
    Interventions
    • Other: MPT Test
    • Other: CLDN15/VIM Test
    Facility
    • Brigham and Women's Hospital, Boston, Massachusetts
    Clinical Trial for Advanced Solid Tumor from Medicenna Therapeutics, Inc.
    Location: San Francisco, California (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Advanced Solid Tumor from Medicenna Therapeutics, Inc.

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    A Phase 1/2 Open Label, Dose Escalation and Expansion Study of MDNA11, IL-2 Superkine, Administered Alone or in Combination With Immune Checkpoint Inhibitor in Patients With Advanced Solid Tumors

    Conditions
    • Non-Small Cell Lung Cancer Squamous
    • Non-Small Cell Lung Cancer Non-squamous
    • Pleural Mesothelioma
    Interventions
    • Drug: MDNA11
    • Drug: Pembrolizumab
    Facility
    • UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California
    • Providence Saint John's Health Center, Santa Monica, California
    • Boca Raton Regional Hospital, Boca Raton, Florida
    • Orlando Health Cancer Institute, Orlando, Florida
    • Emory - Winship Cancer Institute, Atlanta, Georgia
    • Johns Hopkins Hospital, Baltimore, Maryland
    • Karmanos Cancer Institute, Detroit, Michigan
    • MD Anderson Cancer Center, Houston, Texas
    Clinical Trial for Peritoneal Malignant Mesothelioma from National Cancer Institute (NCI)
    Location: Phoenix, Arizona (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Peritoneal Malignant Mesothelioma from National Cancer Institute (NCI)

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    Phase 2 Randomized Trial of Neoadjuvant or Palliative Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma

    Conditions
    • Peritoneal Malignant Mesothelioma
    Interventions
    • Biological: Atezolizumab
    • Biological: Bevacizumab
    • Procedure: Biospecimen Collection
    • Drug: Carboplatin
    • Procedure: Computed Tomography
    • Procedure: Cytoreductive Surgery
    • Drug: Hyperthermic Intraperitoneal Chemotherapy
    • Drug: Pemetrexed
    • Procedure: Positron Emission Tomography
    Facility
    • Mayo Clinic Hospital in Arizona, Phoenix, Arizona
    • University of Chicago Comprehensive Cancer Center, Chicago, Illinois
    • Carle at The Riverfront, Danville, Illinois
    • Carle Physician Group-Effingham, Effingham, Illinois
    • Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois
    • Carle Cancer Center, Urbana, Illinois
    • The Carle Foundation Hospital, Urbana, Illinois
    • University of Kentucky/Markey Cancer Center, Lexington, Kentucky
    • Alliance for Clinical Trials in Oncology, Boston, Massachusetts
    • Sanford Joe Lueken Cancer Center, Bemidji, Minnesota
    • Mercy Hospital, Coon Rapids, Minnesota
    • Fairview Southdale Hospital, Edina, Minnesota
    • Unity Hospital, Fridley, Minnesota
    • Abbott-Northwestern Hospital, Minneapolis, Minnesota
    • Mayo Clinic in Rochester, Rochester, Minnesota
    • Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota
    • Regions Hospital, Saint Paul, Minnesota
    • United Hospital, Saint Paul, Minnesota
    • Sanford Bismarck Medical Center, Bismarck, North Dakota
    • Sanford Broadway Medical Center, Fargo, North Dakota
    • Sanford Roger Maris Cancer Center, Fargo, North Dakota
    • Ohio State University Comprehensive Cancer Center, Columbus, Ohio
    • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
    • University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
    • Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota
    • Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota
    • MD Anderson in The Woodlands, Conroe, Texas
    • M D Anderson Cancer Center, Houston, Texas
    • MD Anderson West Houston, Houston, Texas
    • MD Anderson League City, League City, Texas
    • MD Anderson in Sugar Land, Sugar Land, Texas
    • ThedaCare Regional Cancer Center, Appleton, Wisconsin
    • Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin
    • Marshfield Medical Center-Marshfield, Marshfield, Wisconsin
    • Marshfield Clinic-Minocqua Center, Minocqua, Wisconsin
    • Marshfield Medical Center-Rice Lake, Rice Lake, Wisconsin
    • Marshfield Medical Center-River Region at Stevens Point, Stevens Point, Wisconsin
    • Marshfield Medical Center - Weston, Weston, Wisconsin
    Clinical Trial for Ovarian Cancer from Verismo Therapeutics
    Location: Philadelphia, Pennsylvania (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Ovarian Cancer from Verismo Therapeutics

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    A Phase 1 Study of SynKIR-110, Autologous T Cells Transduced With Mesothelin KIR-CAR, in Subjects With Mesothelin-Expressing Advanced Ovarian Cancer, Cholangiocarcinoma, or Mesothelioma

    Conditions
    • Mesothelioma, Malignant
    Interventions
    • Biological: SynKIR-110, Autologous T cells Transduced with Mesothelin KIR-CAR
    Facility
    • University of Pennsylvania, Philadelphia, Pennsylvania
    • MDAnderson, Houston, Texas
    • University of Wisconsin Carbone Cancer Center, Madison, Wisconsin
    Clinical Trial for Mesothelioma from National Institutes of Health Clinical Center (CC)
    Location: Bethesda, Maryland
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Mesothelioma from National Institutes of Health Clinical Center (CC)

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    Long Term Follow-up of Mesothelioma Patients and Their Family Members With Germline Mutations in BAP1 and Other Genes

    Conditions
    • Mesothelioma
    Facility
    • National Institutes of Health Clinical Center, Bethesda, Maryland
    Clinical Trial for Epitheliod Malignant Pleural Mesothelioma from Abramson Cancer Center at Penn Medicine
    Location: Buffalo, New York (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Epitheliod Malignant Pleural Mesothelioma from Abramson Cancer Center at Penn Medicine

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    A Randomized Phase 2 Trial of Radical Pleurectomy and Post-Operative Chemotherapy With or Without Intraoperative Porfimer Sodium -Mediated Photodynamic Therapy for Patients With Epitheliod Malignant Pleural Mesothelioma

    Conditions
    • Epitheliod Malignant Pleural Mesothelioma
    Interventions
    • Radiation: Photodynamic Therapy
    • Procedure: Radical Pleurectomy
    • Radiation: Chemotherapy
    • Drug: Photofrin 2.0 mg/kg
    Facility
    • Rosewell Park, Buffalo, New York
    • Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania
    Clinical Trial for Mesothelioma from Mayo Clinic
    Location: Rochester, Minnesota
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Mesothelioma from Mayo Clinic

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma

    Conditions
    • Mesothelioma
    • Solitary Fibrous Tumor of the Pleura
    Facility
    • Mayo Clinic in Rochester, Rochester, Minnesota
    Clinical Trial for Malignant Pleural Mesotheliomas NOS from National Institutes of Health Clinical Center (CC)
    Location: Bethesda, Maryland
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Malignant Pleural Mesotheliomas NOS from National Institutes of Health Clinical Center (CC)

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    Prospective Evaluation of Genetic and Epigenetic Alterations in Patients With Thoracic Malignancies

    Conditions
    • Malignant Pleural Mesotheliomas NOS
    • Lung Cancer NOS
    • Thoracic Cancers
    Facility
    • National Institutes of Health Clinical Center, Bethesda, Maryland
    Clinical Trial for Mesothelioma from National Institutes of Health Clinical Center (CC)
    Location: Bethesda, Maryland
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Mesothelioma from National Institutes of Health Clinical Center (CC)

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    Phase II Evaluation of Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma

    Conditions
    • Mesothelioma
    Interventions
    • Drug: Decitabine/cedazuridine
    Facility
    • National Institutes of Health Clinical Center, Bethesda, Maryland
    Clinical Trial for Mesothelioma from Mirati Therapeutics Inc.
    Location: Phoenix, Arizona (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Mesothelioma from Mirati Therapeutics Inc.

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    A Phase 1/2 Multiple Expansion Cohort Trial of MRTX1719 in Patients With Advanced Solid Tumors With Homozygous MTAP Deletion

    Conditions
    • Mesothelioma
    • Non Small Cell Lung Cancer
    Interventions
    • Drug: MRTX1719
    Facility
    • Mayo Clinic, Phoenix, Arizona
    • Sarah Cannon Research Institute at HealthONE, Denver, Colorado
    • Mayo Clinic, Jacksonville, Florida
    • Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando, Florida
    • Dana Farber Cancer Institute, Boston, Massachusetts
    • Mayo Clinic, Rochester, Minnesota
    • Memorial Sloan Kettering Cancer Center, New York, New York
    • NorthShore Hematology Oncology Associates P.C New York Cancer and Blood Specialists, Port Jefferson Station, New York
    • Sarah Cannon Research Institute, Nashville, Tennessee
    • MD Anderson Cancer Center, Houston, Texas
    • Oncology Consultants, P.A., Houston, Texas
    • START Center for Cancer Care, San Antonio, Texas
    • NEXT Virginia, Fairfax, Virginia
    • Froedtert Hospital & the Medical College of Wisconsin, Milwaukee, Wisconsin
    Clinical Trial for Adenocarcinoma from Taproot Health
    Location: Idaho Falls, Idaho (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Adenocarcinoma from Taproot Health

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    The Registry of Oncology Outcomes Associated With Testing and Treatment (ROOT)

    Conditions
    • Lung Cancer
    • Mesothelioma
    Interventions
    • Diagnostic Test: Biomarker Testing (L)
    • Drug: Systemic Treatment (T)
    Facility
    • Teton Cancer Institute, Idaho Falls, Idaho
    • Oncology and Hematology of South Texas, Laredo, Texas
    Clinical Trial for Clear Cell Renal Cell Carcinoma from CRISPR Therapeutics
    Location: Duarte, California (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Clear Cell Renal Cell Carcinoma from CRISPR Therapeutics

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    A Phase 1/2, Open-label, Multicenter, Dose Escalation and Cohort Expansion Study of the Safety and Efficacy of Anti-CD70 Allogeneic CRISPR-Cas9-Engineered T Cells (CTX131) in Adult Subjects With Relapsed or Refractory Solid Tumors

    Conditions
    • Malignant Pleural Mesothelioma
    Interventions
    • Biological: CTX131
    Facility
    • Research Site 3, Duarte, California
    • Research Site 7, Chicago, Illinois
    • Research Site 6, Boston, Massachusetts
    • Research Site 2, Saint Louis, Missouri
    • Research Site 4, Durham, North Carolina
    • Research Site 1, Nashville, Tennessee
    • Research Site 5, Houston, Texas
    Clinical Trial for Solid Tumor, Adult from A2 Biotherapeutics Inc.
    Location: La Jolla, California (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Solid Tumor, Adult from A2 Biotherapeutics Inc.

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    A Seamless Phase 1/2 Study to Evaluate the Safety and Efficacy of A2B694, an Autologous Logic-gated Tmod™ CAR T, in Heterozygous HLA-A*02 Adults With Recurrent Unresectable, Locally Advanced, or Metastatic Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

    Conditions
    • Non Small Cell Lung Cancer
    • Mesothelioma
    • Mesothelioma, Malignant
    • Lung Cancer
    Interventions
    • Biological: A2B694
    • Diagnostic Test: xT CDx with HLA-LOH Assay
    Facility
    • UCSD Moores Cancer Center, La Jolla, California
    • UCLA Medical Center, Los Angeles, California
    • Stanford University, Stanford, California
    • Mayo Clinic, Jacksonville, Florida
    • Moffitt Cancer Center, Tampa, Florida
    • Massachusetts General Hopsital/Dana Farber Cancer Center, Boston, Massachusetts
    • Mayo Clinic Rochester, Rochester, Minnesota
    • Washington University, Saint Louis, Missouri
    • NYU Langone Medical Center, New York, New York
    Clinical Trial for Cancer from Aminex Therapeutics, Inc.
    Location: Phoenix, Arizona (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Cancer from Aminex Therapeutics, Inc.

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    A Phase 1B/2A Study of the Safety, Tolerability and Initial Efficacy of Oral AMXT 1501 Dicaprate and Intravenous Difluoromethylornithine (DFMO) in Patients With Cancer

    Conditions
    • Nsclc
    • Mesotheliomas Pleural
    • Mesothelioma Peritoneum
    Interventions
    • Drug: AMXT1501
    • Drug: DFMO
    Facility
    • Mayo Clinic - Arizona, Phoenix, Arizona
    • Mayo Clinic - Florida, Jacksonville, Florida
    • Mayo Clinic - Minnesota, Rochester, Minnesota
    • Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
    • MD Anderson Cancer Center, Houston, Texas
    • Fred Hutch Cancer Center - Seattle Cancer Care Alliance, Seattle, Washington
    Clinical Trial for Thymus Tumors from National Institutes of Health Clinical Center (CC)
    Location: Bethesda, Maryland
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Thymus Tumors from National Institutes of Health Clinical Center (CC)

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    Inpatient Hospice With Procurement of Tissue on Expiration in Thoracic Malignancies, Bladder Cancer, Ovarian Cancer, Epithelial Cancer and Patients Treated With an Adoptive Cellular Therapy

    Conditions
    • Mesothelioma
    • Lung Cancers
    Facility
    • National Institutes of Health Clinical Center, Bethesda, Maryland
    Clinical Trial for Malignant Pleural Mesothelioma from Memorial Sloan Kettering Cancer Center
    Location: Basking Ridge, New Jersey (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Malignant Pleural Mesothelioma from Memorial Sloan Kettering Cancer Center

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    Breathprinting (E-Nose) Technology to Measure Response to Treatment of Malignant Pleural Mesothelioma (MPM) Through MPM-Specific Volatile Organic Compounds Detected in Exhalates

    Conditions
    • Malignant Pleural Mesothelioma
    Interventions
    • Diagnostic Test: E-Nose testing
    • Diagnostic Test: Research blood
    Facility
    • Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge, New Jersey
    • Memorial Sloan Kettering Monmouth (Consent Only), Middletown, New Jersey
    • Memorial Sloan Kettering Bergen (Consent Only ), Montvale, New Jersey
    • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent Only), Commack, New York
    • Memorial Sloan Kettering Westchester (Consent Only), Harrison, New York
    • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York
    • Memorial Sloan Kettering Nassau (Consent Only), Uniondale, New York
    Clinical Trial for Recurrent Cutaneous Melanoma from M.D. Anderson Cancer Center
    Location: Houston, Texas
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Recurrent Cutaneous Melanoma from M.D. Anderson Cancer Center

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    Ex-Vivo Expanded Allogeneic NK Cells for the Treatment of Solid Tumors of Pediatric Origin in Children and Young Adults

    Conditions
    • Recurrent Malignant Mesothelioma
    • Refractory Malignant Mesothelioma
    Interventions
    • Biological: Cord Blood-derived Expanded Allogeneic Natural Killer Cells
    • Drug: Cyclophosphamide
    • Drug: Etoposide
    Facility
    • M D Anderson Cancer Center, Houston, Texas
    Clinical Trial for Mesothelioma from Brigham and Women's Hospital
    Location: Boston, Massachusetts
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Mesothelioma from Brigham and Women's Hospital

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    MAGIC-AKI: Magnesium for the Prevention of Hyperthermic Intraoperative Cisplatin-Associated AKI

    Conditions
    • Mesothelioma
    Interventions
    • Drug: Magnesium sulfate
    Facility
    • Brigham and Women's Hospital, Boston, Massachusetts
    Clinical Trial for Familial Cancer from National Institutes of Health Clinical Center (CC)
    Location: Bethesda, Maryland
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Familial Cancer from National Institutes of Health Clinical Center (CC)

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome

    Conditions
    • Mesothelioma
    Facility
    • National Institutes of Health Clinical Center, Bethesda, Maryland
    Clinical Trial for Mesothelioma from Mayo Clinic
    Location: Rochester, Minnesota
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Mesothelioma from Mayo Clinic

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    Surgery for Mesothelioma After Radiation Therapy "SMART" for Resectable Malignant Pleural Mesothelioma

    Conditions
    • Mesothelioma
    • Solitary Fibrous Tumor of the Pleura
    Facility
    • Mayo Clinic in Rochester, Rochester, Minnesota
    Clinical Trial for Advanced/Metastatic Solid Tumor from Kezar Life Sciences, Inc.
    Location: Los Angeles, California (multiple locations)
    Call (866) 608-8933 to get help enrolling in this clinical trial
    Clinical Trial for Advanced/Metastatic Solid Tumor from Kezar Life Sciences, Inc.

    Our Patient Advocates can help you connect with clinical trials

    Call (866) 608-8933 to get started

    Trial Name
    A Phase 1 Study of KZR-261, a Small Molecule Sec61 Inhibitor, in Subjects With Advanced Solid Malignancies

    Conditions
      Interventions
      • Drug: KZR-261
      Facility
      • Cedars Sinai Medical Center, Los Angeles, California
      • University of California Los Angeles, Los Angeles, California
      • Moffitt Cancer Center, Tampa, Florida
      • Winship Cancer Institute of Emory University, Atlanta, Georgia
      • University Hospitals - Cleveland Medical Center, Cleveland, Ohio
      • Fox Chase Cancer Center, Philadelphia, Pennsylvania
      • Sara Cannon Research Institution (SCRI) - Tennessee Oncology Nashville, Nashville, Tennessee
      • START (South Texas Accelerated Research Therapeutics), San Antonio, Texas
      • Virginia Cancer Specialists (VCS), Fairfax, Virginia
      Clinical Trial for Advanced Solid Tumors from PharmaMar
      Location: Santa Monica, California (multiple locations)
      Call (866) 608-8933 to get help enrolling in this clinical trial
      Clinical Trial for Advanced Solid Tumors from PharmaMar

      Our Patient Advocates can help you connect with clinical trials

      Call (866) 608-8933 to get started

      Trial Name
      Phase I/II, Multicenter, Open-label, Clinical and Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Pretreated Patients With Selected Advanced Solid Tumors

      Conditions
      • Soft Tissue Sarcoma (Excluding GIST)
      • Mesothelioma
      Interventions
      • Drug: Lurbinectedin
      • Drug: Irinotecan
      Facility
      • Sarcoma Oncology Center, Santa Monica, California
      • Massachusetts General Hospital -, Boston, Massachusetts
      • Beth Israel Deaconess Medical Center, Boston, Massachusetts
      • The University of Texas MD Anderson Cancer Center, Houston, Texas
      Clinical Trial for Solid Tumor, Adult from A2 Biotherapeutics Inc.
      Location: Gilbert, Arizona (multiple locations)
      Call (866) 608-8933 to get help enrolling in this clinical trial
      Clinical Trial for Solid Tumor, Adult from A2 Biotherapeutics Inc.

      Our Patient Advocates can help you connect with clinical trials

      Call (866) 608-8933 to get started

      Trial Name
      An Observational Study Obtaining Solid Tumor Tissue From Participants and Apheresis for CAR T-Cell Therapy Manufacturing

      Conditions
      • Non Small Cell Lung Cancer
      • Mesothelioma
      • Mesothelioma, Malignant
      • Mesothelioma; Lung
      Facility
      • Banner Health, Gilbert, Arizona
      • City of Hope, Duarte, California
      • University of California San Diego, La Jolla, California
      • Stanford University, Palo Alto, California
      • UCLA Medical Center, Santa Monica, California
      • Mayo Clinic Jacksonville, Jacksonville, Florida
      • Moffitt Cancer Center, Tampa, Florida
      • Massachusetts General Hospital/Dana Farber Cancer Institute, Boston, Massachusetts
      • Mayo Clinic Rochester, Rochester, Minnesota
      • Washington University, Saint Louis, Missouri
      • NYU Langone Medical Center, New York, New York
      • MD Anderson Cancer Center, Houston, Texas
      • Fred Hutchinson Cancer Center, Seattle, Washington
      Clinical Trial for Malignant Pleural Mesothelioma from Oncovir, Inc.
      Location: New York, New York
      Call (866) 608-8933 to get help enrolling in this clinical trial
      Clinical Trial for Malignant Pleural Mesothelioma from Oncovir, Inc.

      Our Patient Advocates can help you connect with clinical trials

      Call (866) 608-8933 to get started

      Trial Name
      Direct Injection of Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma

      Conditions
      • Malignant Pleural Mesothelioma
      Interventions
      • Biological: Safety
      Facility
      • Icahn School of Medicine Mount Sinai, New York, New York
      Clinical Trial for Mesotheliomas Pleural from Abramson Cancer Center at Penn Medicine
      Location: Philadelphia, Pennsylvania
      Call (866) 608-8933 to get help enrolling in this clinical trial
      Clinical Trial for Mesotheliomas Pleural from Abramson Cancer Center at Penn Medicine

      Our Patient Advocates can help you connect with clinical trials

      Call (866) 608-8933 to get started

      Trial Name
      Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)

      Conditions
      • Mesotheliomas Pleural
      Interventions
      • Drug: Pembrolizumab
      • Procedure: Indocyanine Green (ICG) Image-Guided Surgery
      • Drug: Cisplatin
      • Drug: Pemetrexed
      Facility
      • Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania
      Clinical Trial for Mesothelioma from Mayo Clinic
      Location: Rochester, Minnesota
      Call (866) 608-8933 to get help enrolling in this clinical trial
      Clinical Trial for Mesothelioma from Mayo Clinic

      Our Patient Advocates can help you connect with clinical trials

      Call (866) 608-8933 to get started

      Trial Name
      Staging Procedures to Diagnose Malignant Pleural Mesothelioma

      Conditions
      • Mesothelioma
      • Solitary Fibrous Tumor of the Pleura
      Facility
      • Mayo Clinic in Rochester, Rochester, Minnesota
      Clinical Trial for Uveal Melanoma from Ohio State University
      Location: Columbus, Ohio
      Call (866) 608-8933 to get help enrolling in this clinical trial
      Clinical Trial for Uveal Melanoma from Ohio State University

      Our Patient Advocates can help you connect with clinical trials

      Call (866) 608-8933 to get started

      Trial Name
      Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome

      Conditions
      • BAP1 Gene Mutation
      • Mesothelioma
      Facility
      • The Ohio State University Wexner Medical Center, Columbus, Ohio
      Clinical Trial for Malignant Pleural Mesothelioma (MPM) from Memorial Sloan Kettering Cancer Center
      Location: New York, New York
      Call (866) 608-8933 to get help enrolling in this clinical trial
      Clinical Trial for Malignant Pleural Mesothelioma (MPM) from Memorial Sloan Kettering Cancer Center

      Our Patient Advocates can help you connect with clinical trials

      Call (866) 608-8933 to get started

      Trial Name
      A Single-Arm, Open-Label, Phase I Trial to Assess the Safety of Genetically Engineered Autologous T Cells Targeting the Cell Surface Antigen Mesothelin With Cell-Intrinsic Checkpoint Inhibition in Patients With Mesothelioma

      Conditions
      • Malignant Pleural Mesothelioma (MPM)
      Interventions
      • Drug: cyclophosphamide
      • Biological: CAR T cells
      Facility
      • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York
      Clinical Trial for Ovarian Carcinoma from Numab Therapeutics AG
      Location: Los Angeles, California (multiple locations)
      Call (866) 608-8933 to get help enrolling in this clinical trial
      Clinical Trial for Ovarian Carcinoma from Numab Therapeutics AG

      Our Patient Advocates can help you connect with clinical trials

      Call (866) 608-8933 to get started

      Trial Name
      A Phase 1 Study of NM32-2668 (Anti-ROR1/CD3/Anti-HSA Tri-Specific Antibody) in Adult Patients With Selected Advanced Solid Tumors

      Conditions
      • Peritoneal Carcinoma
      • Mesothelioma, Malignant
      Interventions
      • Biological: NM32-2668
      Facility
      • USC Norris Comprehensive Cancer Center, Los Angeles, California
      • Cleveland Clinic, Cleveland, Ohio
      • University of Pittsburgh Medical Center (UPMC) - Hillman Cancer Center, Pittsburgh, Pennsylvania
      • Lifespan Cancer Institute at Rhode Island Hospital, Providence, Rhode Island
      • Mary Crowley Cancer Research, Dallas, Texas
      Clinical Trial for Mesothelioma from University of Chicago
      Location: Chicago, Illinois
      Call (866) 608-8933 to get help enrolling in this clinical trial
      Clinical Trial for Mesothelioma from University of Chicago

      Our Patient Advocates can help you connect with clinical trials

      Call (866) 608-8933 to get started

      Trial Name
      Phase II Trial of Olaparib in Homologous Recombination Deficient (HRD) Malignant Mesothelioma

      Conditions
      • Mesothelioma
      Interventions
      • Drug: Olaparib
      Facility
      • University of Chicago Medical Center, Chicago, Illinois
      Clinical Trial for Advanced Renal Cell Carcinoma from M.D. Anderson Cancer Center
      Location: Houston, Texas
      Call (866) 608-8933 to get help enrolling in this clinical trial
      Clinical Trial for Advanced Renal Cell Carcinoma from M.D. Anderson Cancer Center

      Our Patient Advocates can help you connect with clinical trials

      Call (866) 608-8933 to get started

      Trial Name
      Phase I/II Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma

      Conditions
        Interventions
        • Drug: CAR.70/IL15-transduced CB-derived NK cells
        • Drug: Fludarabine phosphate
        • Drug: Cyclophosphamide
        Facility
        • M D Anderson Cancer Center, Houston, Texas
        Clinical Trial for Locally Advanced Solid Tumor from Tango Therapeutics, Inc.
        Location: Los Angeles, California (multiple locations)
        Call (866) 608-8933 to get help enrolling in this clinical trial
        Clinical Trial for Locally Advanced Solid Tumor from Tango Therapeutics, Inc.

        Our Patient Advocates can help you connect with clinical trials

        Call (866) 608-8933 to get started

        Trial Name
        A Phase 1/2, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Anti-tumor Activity of TNG908 in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors

        Conditions
          Interventions
          • Drug: TNG908
          Facility
          • University of California Los Angeles, Los Angeles, California
          • University of California San Francisco, San Francisco, California
          • Northwestern University, Chicago, Illinois
          • Massachusetts General Hospital, Boston, Massachusetts
          • Dana Farber Cancer Institute, Boston, Massachusetts
          • Washington University, Saint Louis, Missouri
          • Memorial Sloan Kettering Cancer Center, New York, New York
          • Sarah Cannon Tennessee Oncology, Nashville, Tennessee
          • The University of Texas MD Anderson Cancer Center, Houston, Texas
          • NEXT Oncology, Fairfax, Virginia
          Clinical Trial for Solid Tumors from Inhibrx, Inc.
          Location: Scottsdale, Arizona (multiple locations)
          Call (866) 608-8933 to get help enrolling in this clinical trial
          Clinical Trial for Solid Tumors from Inhibrx, Inc.

          Our Patient Advocates can help you connect with clinical trials

          Call (866) 608-8933 to get started

          Trial Name
          An Open-Label, Multicenter, First-in-Human, Phase 1 Dose-Escalation and Multicohort Expansion Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

          Conditions
          • Malignant Pleural Mesothelioma
          Interventions
          • Drug: INBRX-109
          Facility
          • HonorHealth Research Institute, Scottsdale, Arizona
          • City of Hope, Duarte, California
          • Valkyrie Clinical Trials, Los Angeles, California
          • University of California, San Diego (UCSD) - Moores Cancer Center, San Diego, California
          • Sarcoma Oncology Center, Santa Monica, California
          • University of Colorado Hospital, Aurora, Colorado
          • Emory University - Winship Cancer Institute, Atlanta, Georgia
          • The University of Chicago, Chicago, Illinois
          • Center for Cancer Research at NCI, Bethesda, Maryland
          • University of Michigan, Ann Arbor, Michigan
          • START Midwest Michigan, PC, Grand Rapids, Michigan
          • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York, New York
          • Cleveland Clinic, Cleveland, Ohio
          • Oregon Health & Science University, Portland, Oregon
          • University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania
          • Vanderbilt University School of Medicine, Nashville, Tennessee
          • UT MD Anderson Cancer Center, Houston, Texas
          • NEXT Oncology, San Antonio, Texas
          • NEXT Oncology - Virginia, Fairfax, Virginia
          Clinical Trial for Nasopharyngeal Carcinoma from Ascentage Pharma Group Inc.
          Location: Springdale, Arkansas
          Call (866) 608-8933 to get help enrolling in this clinical trial
          Clinical Trial for Nasopharyngeal Carcinoma from Ascentage Pharma Group Inc.

          Our Patient Advocates can help you connect with clinical trials

          Call (866) 608-8933 to get started

          Trial Name
          A Phase I Study of Safety, Pharmacokinetic and Efficacy of Orally Administered APG-5918 in Patients With Advanced Solid Tumors or Hematologic Malignancies

          Conditions
          • Mesothelioma
          Interventions
          • Drug: APG-5918
          Facility
          • Highlands Oncology, Springdale, Arkansas
          Clinical Trial for Pancreatic Cancer from University of Nebraska
          Location: Colorado Springs, Colorado (multiple locations)
          Call (866) 608-8933 to get help enrolling in this clinical trial
          Clinical Trial for Pancreatic Cancer from University of Nebraska

          Our Patient Advocates can help you connect with clinical trials

          Call (866) 608-8933 to get started

          Trial Name
          Integrated Cancer Repository for Cancer Research

          Conditions
          • Lung Cancer
          • Peritoneal Surface Malignancies
          • Mesothelioma
          Facility
          • Penrose Cancer Center, Colorado Springs, Colorado
          • Porter Adventist Hospital, Denver, Colorado
          • Mercy Regional Medical Center, Durango, Colorado
          • St. Anthony Hospital, Lakewood, Colorado
          • Littleton Cancer Center, Littleton, Colorado
          • Longmont Cancer Center, Longmont, Colorado
          • Avista Cancer Center, Louisville, Colorado
          • Parker Adventist Hospital, Parker, Colorado
          • St. Mary Corwin Medical Center, Pueblo, Colorado
          • St. Anthony North Cancer Center, Westminster, Colorado
          • Bristol Health Beekley, Bristol, Connecticut
          • Florida Hospital Memorial Medical Center, Daytona Beach, Florida
          • Florida Hospital DeLand, DeLand, Florida
          • Florida Hospital FISH, Orange City, Florida
          • Florida Hospital Flagler, Palm Coast, Florida
          • Tallahassee Memorial Hospital, Tallahassee, Florida
          • Rush-Copley Cancer Care Center, Aurora, Illinois
          • Trinity Medical Center, Moline, Illinois
          • Rush-Copley Healthcare Center, Yorkville, Illinois
          • Parkview Research Center, Fort Wayne, Indiana
          • Community Health Network, Indianapolis, Indiana
          • Community Cancer Center South, Indianapolis, Indiana
          • Community Cancer Center North, Indianapolis, Indiana
          • Community Howard Regional Hospital, Kokomo, Indiana
          • Methodist Jennie Edmundson Hospital, Council Bluffs, Iowa
          • Genesis Medical Center, Davenport, Iowa
          • Abben Cancer Center, Spencer, Iowa
          • Covenant Medical Center, Inc, Waterloo, Iowa
          • Saint Luke's Cancer Instititue - South, Overland Park, Kansas
          • Tulane University, New Orleans, Louisiana
          • Breast Care Specialists of Maine, Portland, Maine
          • Northwest Hospital, Randallstown, Maryland
          • William E Kahlert Regional Cancer Center, Westminster, Maryland
          • Holyoke Medical Center, Holyoke, Massachusetts
          • University of Michigan Health System, Ann Arbor, Michigan
          • Riverwood Healthcare Center, Aitkin, Minnesota
          • Essentia Health-St. Joseph's Medical Center, Brainerd, Minnesota
          • Essentia Health - Duluth Clinic, Duluth, Minnesota
          • St. Luke's Hospital of Duluth, Duluth, Minnesota
          • Lake Region Healthcare, Fergus Falls, Minnesota
          • Avera Cancer Institute- Marshall, Marshall, Minnesota
          • Mercy Hospital - Joplin, Joplin, Missouri
          • Saint Luke's Cancer Institute, East, Kansas City, Missouri
          • Saint Luke's Cancer Institute, Kansas City, Missouri
          • Saint Luke's Cancer Institute, Kansas City North, Kansas City, Missouri
          • Saint Luke's Cancer Institute, Liberty, Liberty, Missouri
          • Heartland Regional Medical Center dba Mosaic Life Care, Saint Joseph, Missouri
          • Bozeman Health Deaconess Hospital, Bozeman, Montana
          • Logan Health, Kalispell, Montana
          • Providence St. Patrick Hospital Montana Cancer Center, Missoula, Montana
          • Mary Lanning Healthcare, Morrison Cancer Center, Hastings, Nebraska
          • Faith Regional Health Services, Carson Cancer Center, Norfolk, Nebraska
          • Great Plains Regional Medical Center, North Platte, Nebraska
          • Avera St. Anthony's Hospital, O'Neill, Nebraska
          • Methodist Estabrook Cancer Center, Omaha, Nebraska
          • Nebraska Methodist Health System, Omaha, Nebraska
          • University of Nebraska Medical Center, Omaha, Nebraska
          • Regional West Health Services, Scottsbluff, Nebraska
          • C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls, New York
          • Faxton St. Luke's Healthcare, Mohawk Valley, Utica, New York
          • Cape Fear Valley Health System, Fayetteville, North Carolina
          • Essentia Health, Fargo, North Dakota
          • Trinity Hospital Cancer Care Center, Minot, North Dakota
          • Aultman Alliance Community Hospital, Alliance, Ohio
          • Aultman Hospital, Canton, Ohio
          • University of Pittsburgh, Pittsburgh, Pennsylvania
          • Avera Medical Group Oncology and Hematology Aberdeen, Aberdeen, South Dakota
          • Avera Cancer Institute, Mitchell, South Dakota
          • Avera Cancer Institute, Sioux Falls, South Dakota
          • Sanford Health, Sioux Falls, South Dakota
          • Avera Cancer Center Yankton, Yankton, South Dakota
          • Avera Sacred Heart Hospital, Yankton, South Dakota
          • Yankton Medical Clinic, Yankton, South Dakota
          • Rutland Regional Medical Center, Rutland, Vermont
          • Mary Washington Hospital, Fredericksburg, Virginia
          • Ascension St. Elizabeth Hospital, Appleton, Wisconsin
          • Wheaton Franciscan Healthcare - Elmbrook Memorial Hospital, Brookfield, Wisconsin
          • Wheaton Franciscan Healthcare, Reiman Cancer Care, Franklin, Wisconsin
          • Bellin Memorial Hospital, Green Bay, Wisconsin
          • Columbia St. Mary's, Mequon, Wisconsin
          • Columbia St. Mary's, Milwaukee, Wisconsin
          • Ascension Mercy Hospital, Oshkosh, Wisconsin
          • Wheaton Franciscan Healthcare, All Saints, Racine, Wisconsin
          • Wheaton Franciscan Healthcare, Wauwatosa Cancer Care, Wauwatosa, Wisconsin
          Clinical Trial for Mesothelioma from NGM Biopharmaceuticals, Inc
          Location: Los Angeles, California (multiple locations)
          Call (866) 608-8933 to get help enrolling in this clinical trial
          Clinical Trial for Mesothelioma from NGM Biopharmaceuticals, Inc

          Our Patient Advocates can help you connect with clinical trials

          Call (866) 608-8933 to get started

          Trial Name
          A Phase 1/2 Dose Escalation/Expansion Study of NGM707 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

          Conditions
          • Mesothelioma
          • Non Small Cell Lung Cancer
          Interventions
          • Drug: NGM707
          Facility
          • University of Southern California, Los Angeles, California
          • Hoag Memorial Hospital Presbyterian, Newport Beach, California
          • UCLA Medical Center, Santa Monica, California
          • Georgetown University Medical Center, Washington, District of Columbia
          • Florida Cancer Specialists - Sarasota - SCRI, Sarasota, Florida
          • University of Maryland Greenebaum Cancer Center, Baltimore, Maryland
          • Dana-Farber Cancer Institute, Boston, Massachusetts
          • START Midwest, LLC, Grand Rapids, Michigan
          • Nebraska Cancer Specialists, Omaha, Nebraska
          • Prisma Health - Upstate, Greenville, South Carolina
          • University of Texas Southwestern Medical Center, Dallas, Texas
          • MD Anderson Cancer Center, Houston, Texas
          • NEXT Oncology, San Antonio, Texas
          Clinical Trial for Solid Tumor, Adult from Vivace Therapeutics, Inc
          Location: Chicago, Illinois (multiple locations)
          Call (866) 608-8933 to get help enrolling in this clinical trial
          Clinical Trial for Solid Tumor, Adult from Vivace Therapeutics, Inc

          Our Patient Advocates can help you connect with clinical trials

          Call (866) 608-8933 to get started

          Trial Name
          Phase 1, Multi-Center, Open-Label Study of VT3989 in Patients With Refractory Locally Advanced or Metastatic Solid Tumors Enriched for Tumors Harboring Mutations of the Neurofibromatosis Type 2 Gene (Mutant NF2 or mNF2)

          Conditions
          • Mesothelioma
          Interventions
          • Drug: VT3989
          Facility
          • University of Chicago Medical Center, Chicago, Illinois
          • Massachusetts General Hospital, Boston, Massachusetts
          • Dana-Farber Cancer Institute, Boston, Massachusetts
          • Memorial Sloan Kettering Cancer Center-, New York, New York
          • MD Anderson Cancer Center, Houston, Texas
          • NEXT Oncology, San Antonio, Texas
          Clinical Trial for Solid Tumors, Adult from Ikena Oncology
          Location: Los Angeles, California (multiple locations)
          Call (866) 608-8933 to get help enrolling in this clinical trial
          Clinical Trial for Solid Tumors, Adult from Ikena Oncology

          Our Patient Advocates can help you connect with clinical trials

          Call (866) 608-8933 to get started

          Trial Name
          A Phase 1, First-in-Human Study of IK-930, an Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects With Advanced Solid Tumors

          Conditions
          • Malignant Pleural Mesothelioma (MPM)
          Interventions
          • Drug: IK-930
          Facility
          • University of California Los Angeles, Los Angeles, California
          • The University of Chicago, Chicago, Illinois
          • Massachusetts General Hospital, Boston, Massachusetts
          • Start Midwest, Grand Rapids, Michigan
          • Memorial Sloan Kettering Cancer Center, New York, New York
          • University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania
          • Sidney Kimmel Cancer Center at Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
          • Sarah Cannon Research Institute, Nashville, Tennessee
          • MD Anderson Cancer Center, Houston, Texas
          • Next Oncology, San Antonio, Texas
          Clinical Trial for Head and Neck Carcinoma from VM Oncology, LLC
          Location: Duarte, California (multiple locations)
          Call (866) 608-8933 to get help enrolling in this clinical trial
          Clinical Trial for Head and Neck Carcinoma from VM Oncology, LLC

          Our Patient Advocates can help you connect with clinical trials

          Call (866) 608-8933 to get started

          Trial Name
          An Open-Label, Multiple-Dose, Dose-Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of VMD-928 in Subjects With Solid Tumors or Lymphoma

          Conditions
          • Lung Cancer
          • Mesothelioma
          Interventions
          • Drug: VMD-928 300 mg Tablet (ongoing); 100 mg Capsule (complete)
          Facility
          • City of Hope National Medical Center, Duarte, California
          • Memorial Cancer Institute at Memorial Healthcare Systems, Pembroke Pines, Florida
          • Atlantic Health System, Morristown Medical Center, Morristown, New Jersey
          • Cayuga Medical Center, Ithaca, New York
          • Weill Cornell Medicine, Cornell University, New York, New York
          • Gabrail Cancer Center Research, Canton, Ohio
          • Erlanger Health System (Hospital); University of Tennessee College of Medicine, Chattanooga, Chattanooga, Tennessee
          • The University of Texas MD Anderson Cancer Center, Houston, Texas
          • Medical College of Wisconsin, Milwaukee, Wisconsin
          Clinical Trial for Gastric Cancer from HiFiBiO Therapeutics
          Location: Scottsdale, Arizona (multiple locations)
          Call (866) 608-8933 to get help enrolling in this clinical trial
          Clinical Trial for Gastric Cancer from HiFiBiO Therapeutics

          Our Patient Advocates can help you connect with clinical trials

          Call (866) 608-8933 to get started

          Trial Name
          A Phase 1a/1b, Open-Label, Multi-Center, Dose Escalation and Expansion Study of HFB200301 (TNFR2 Agonist Antibody) as a Single Agent and in Combination With Tislelizumab (Anti-PD-1 Antibody) in Adult Patients With Advanced Solid Tumors

          Conditions
          • Mesothelioma
          • Non Small Cell Lung Cancer
          Interventions
          • Drug: HFB200301
          Facility
          • Mayo Clinic, Scottsdale, Arizona
          • USC/Norris Comprehensive Cancer Center, Los Angeles, California
          • Mayo Clinic, Jacksonville, Florida
          • Mayo Clinic, Rochester, Minnesota
          • Washington University School of Medicine, Saint Louis, Missouri
          • The University of Texas, MD Anderson Cancer Center, Houston, Texas
          • NEXT Virginia Cancer Specialists, Fairfax, Virginia
          Clinical Trial for Unresectable Pleural Mesothelioma from AstraZeneca
          Location: Phoenix, Arizona (multiple locations)
          Call (866) 608-8933 to get help enrolling in this clinical trial
          Clinical Trial for Unresectable Pleural Mesothelioma from AstraZeneca

          Our Patient Advocates can help you connect with clinical trials

          Call (866) 608-8933 to get started

          Trial Name
          A Phase III, Randomized, Open-Label, Multicenter, Global Study of Volrustomig (MEDI5752) in Combination With Carboplatin Plus Pemetrexed Versus Platinum Plus Pemetrexed or Nivolumab Plus Ipilimumab in Participants With Unresectable Pleural Mesothelioma (eVOLVE-Meso)

          Conditions
            Interventions
            • Drug: Volrustomig
            • Drug: Pemetrexed
            • Drug: Carboplatin
            Facility
            • Research Site, Phoenix, Arizona
            • Research Site, Duarte, California
            • Research Site, Santa Rosa, California
            • Research Site, Aurora, Colorado
            • Research Site, Jacksonville, Florida
            • Research Site, Atlanta, Georgia
            • Research Site, Chicago, Illinois
            • Research Site, Rochester, Minnesota
            • Research Site, Saint Louis, Missouri
            • Research Site, East Brunswick, New Jersey
            • Research Site, Commack, New York
            • Research Site, Cleveland, Ohio
            • Research Site, Columbus, Ohio
            • Research Site, Portland, Oregon
            • Research Site, Portland, Oregon
            • Research Site, Philadelphia, Pennsylvania
            • Research Site, Houston, Texas
            • Research Site, Fairfax, Virginia
            Clinical Trial for Gastric Cancer from University of Pittsburgh
            Location: Pittsburgh, Pennsylvania
            Call (866) 608-8933 to get help enrolling in this clinical trial
            Clinical Trial for Gastric Cancer from University of Pittsburgh

            Our Patient Advocates can help you connect with clinical trials

            Call (866) 608-8933 to get started

            Trial Name
            A Phase 2 Study to Evaluate the Efficacy and Safety of Adoptive Transfer of Autologous Tumor Infiltrating Lymphocytes in Patients With Advanced Solid Cancers

            Conditions
            • Mesothelioma
            Interventions
            • Biological: Tumor Infiltrating Lymphocytes (TIL)
            • Drug: Fludarabine + Cyclophosphamide combination
            Facility
            • UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania
            Clinical Trial for Locally Advanced Solid Tumor from Compass Therapeutics
            Location: Ocala, Florida (multiple locations)
            Call (866) 608-8933 to get help enrolling in this clinical trial
            Clinical Trial for Locally Advanced Solid Tumor from Compass Therapeutics

            Our Patient Advocates can help you connect with clinical trials

            Call (866) 608-8933 to get started

            Trial Name
            A Phase 1, Open-Label, Multiple-Ascending Dose Study of the Safety and Tolerability of CTX-471 Administered Either as a Monotherapy or in Combination With Pembrolizumab in Patients With Inadequate Responses to PD-1/PD-L1 Checkpoint Inhibitors in Metastatic or Locally Advanced Malignancies

            Conditions
            • Metastatic Cancer
            • Non-small Cell Lung Cancer
            • Small Cell Lung Cancer
            • Mesothelioma
            Interventions
            • Drug: CTX-471
            Facility
            • Ocala Oncology Center, Ocala, Florida
            • Hematology Oncology Associates Of The Treasure Coast, Port Saint Lucie, Florida
            • Massachusetts General Hospital, Boston, Massachusetts
            • Dana-Farber Cancer Institute, Boston, Massachusetts
            • Washington University School of Medicine, Siteman Cancer Center, Saint Louis, Missouri
            • Hackensack University Medical Center, Hackensack, New Jersey
            • Mt Sinai, New York, New York
            • Duke University School of Medicine, Durham, North Carolina
            • Institute for Translational Oncology Research (ITOR), Greenville, South Carolina
            • Mary Crowley Cancer Research, Dallas, Texas
            Clinical Trial for Pancreatic Cancer from Takeda
            Location: Birmingham, Alabama (multiple locations)
            Call (866) 608-8933 to get help enrolling in this clinical trial
            Clinical Trial for Pancreatic Cancer from Takeda

            Our Patient Advocates can help you connect with clinical trials

            Call (866) 608-8933 to get started

            Trial Name
            An Open-label, Dose Escalation and Expansion, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of TAK-500, a Novel Stimulator of Interferon Genes Agonist, as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Select Locally Advanced or Metastatic Solid Tumors

            Conditions
            • Mesothelioma
            • Non-small Cell Lung Cancer (NSCLC), Non-squamous
            Interventions
            • Drug: TAK-500
            Facility
            • Univeristy of Alabama at Birmingham, Birmingham, Alabama
            • City of Hope Comprehensive Cancer Center, Duarte, California
            • University of California San Diego, La Jolla, California
            • University of Colorado - Anschutz Medical Campus - PPDS, Aurora, Colorado
            • Sarah Cannon Research Institute, Denver, Colorado
            • Sylvester Comprehensive Cancer Center, Miami, Florida
            • Northwestern, Chicago, Illinois
            • Dana Farber Cancer Institute, Boston, Massachusetts
            • New York University, New York, New York
            • Fox Chase Cancer Center, Philadelphia, Pennsylvania
            • Sarah Cannon Cancer Institute, Nashville, Tennessee
            • START South Texas Accelerated Research Therapeutics, San Antonio, Texas
            of Don't see what you're looking for? Call (866) 608-8933 so one of our Patient Advocates can help you find the right clinical trial.

            What State Has the Highest Rate of Mesothelioma?

            California ranks first among states with the most mesothelioma cases. A total of 6,503 Californians were diagnosed with mesothelioma between 1999 and 2018, according to the Centers for Disease Control and Prevention (CDC).

            Mesothelioma Rates by State

            Some states have higher rates of mesothelioma because they have a long history of industries that heavily relied on asbestos, such as shipbuilding, mining, and manufacturing.

            According to CDC data, these 10 states have the highest incidence rates for mesothelioma:

            StateMesothelioma CasesPopulationIncidence Rate
            1. Maine51326,350,6901.5%
            2. Alaska12813,839,0161.4%
            3. New Jersey2,654174,234,0481.4%
            4. Delaware27217,554,4991.4%
            5. Washington1,799132,284,0231.3%
            6. Louisiana1,22890,660,6761.3%
            7. West Virginia61436,590,1721.3%
            8. Wyoming14710,870,0111.3%
            9. Pennsylvania4,040251,711,6171.3%
            10. Wisconsin1,581112,331,9091.3%

            Thankfully, there are experienced specialists in each of these states who can treat people diagnosed with mesothelioma and other asbestos-related diseases.

            Learn more about treatments, specialists, and help for asbestos exposure in our Free Mesothelioma Guide — shipped overnight to your door.

            Mesothelioma Guide Images
            Get Your Free 2024 Mesothelioma Guide
            • Symptoms & staging
            • Average prognosis
            • Life-extending treatments

            Get Your Free Guide

            Find Mesothelioma Treatment Near You Today

            Locating mesothelioma treatment near you is a crucial step you can take toward fighting this rare cancer. With advancements in mesothelioma research and treatment options, there is increasing hope for better survival outcomes and improved quality of life.

            Our highly trained Patient Advocates can help you connect with mesothelioma doctors and treatment centers in your state. We can also see if you qualify for financial assistance that can help pay for your cancer treatments.

            Find a mesothelioma specialist in your state to get started.

            Jenna TozziWritten by:

            Director of Patient Advocacy

            Jenna Tozzi, RN, is the Director of Patient Advocacy at Mesothelioma Hope. With more than 15 years of experience as an adult and pediatric oncology nurse navigator, Jenna provides exceptional guidance and support to mesothelioma patients and their loved ones. Jenna has been featured in Oncology Nursing News and is a member of the Academy of Oncology Nurse & Patient Navigators & the American Nurses Association.

            Our Promise to You
            Our Promise to You
            References
            1. American Cancer Society. (2018, November 16). Chemotherapy for malignant mesothelioma. Retrieved February 15, 2024, from https://www.cancer.org/cancer/types/malignant-mesothelioma/treating/chemotherapy.html
            2. American Cancer Society. (2018, November 16). Immunotherapy for malignant mesothelioma. Retrieved February 15, 2024, from https://www.cancer.org/cancer/types/malignant-mesothelioma/treating/immunotherapy.html
            3. American Cancer Society. (2018, November 16). Radiation for malignant mesothelioma. Retrieved February 15, 2024, from https://www.cancer.org/cancer/types/malignant-mesothelioma/treating/radiation.html
            4. American Cancer Society. (2018, November 16). Surgery for malignant mesothelioma. Retrieved February 15, 2024, from https://www.cancer.org/cancer/types/malignant-mesothelioma/treating/surgery.html
            5. American Cancer Society. (2019, May 18). What’s New in Malignant Mesothelioma Research? Retrieved February 15, 2024, from https://www.cancer.org/cancer/malignant-mesothelioma/about/new-research.html
            6. Bou-Samra, P., et al. (2023). Epidemiological, therapeutic, and survival trends in malignant pleural mesothelioma: A review of the National Cancer Database. Cancer Medicine. Retrieved February 15, 2024, from https://onlinelibrary.wiley.com/doi/full/10.1002/cam4.5915
            7. Cancer Therapy Advisor. (2017). Pleural plaques/Mesothelioma. Retrieved February 15, 2024, from https://www.cancertherapyadvisor.com/home/decision-support-in-medicine/hospital-medicine/pleural-plaques-mesothelioma/
            8. Centers for Disease Control and Prevention. (2023). United States and Puerto Rico Cancer Statistics, 1999-2018 Incidence Archive Request. Retrieved February 15, 2024, from https://wonder.cdc.gov/controller/datarequest/D172;jsessionid=DA3FC143B54F55C2AAA615EBC193?stage=results&action=sort&direction=MEASURE_DESCEND&measure=D172.M1
            9. MD Anderson Cancer Center. (2021, July 14). Atezolizumab and bevacizumab show meaningful responses for malignant peritoneal mesothelioma patients. Retrieved February 15, 2024 from https://www.mdanderson.org/newsroom/atezolizumab-and-bevacizumab-show-meaningful-responses-for-malignant-peritoneal-mesothelioma-patients.h00-159462423.html
            10. National Cancer Institute. (n.d.). Find a Cancer Center. Retrieved February 15, 2024, from https://www.cancer.gov/research/infrastructure/cancer-centers/find
            11. National Cancer Institute (2019, June 24). NCI-Designated Cancer Centers. Retrieved February 15, 2024, from https://www.cancer.gov/research/infrastructure/cancer-centers
            12. Rossini, M., et al. (2018). New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma. Frontiers in Oncology. Retrieved February 15, 2024, from https://www.frontiersin.org/articles/10.3389/fonc.2018.00091/full
            Free 30-Minute ConversationWith Jenna Tozzi, RN
            Fill Out Your Contact Information
            How We Can Help

            Mesothelioma Hope is passionate about helping patients and families affected by this aggressive cancer. A mesothelioma diagnosis can be scary and isolating, but we’re here for you at every step. Hope is only a phone call away.

            (866) 608-8933
            Medical Guidance
            • Get a second opinion
            • Find a doctor or cancer center
            • Access clinical trials
            • Improve your quality of life
            Financial Assistance
            • Access $30 billion in trust funds
            • File a mesothelioma claim
            • Increase your VA benefits
            • Apply for travel grants
            Supportive Care
            • Find a support group or peer mentor
            • Get help with daily tasks
            • Explore respite care options
            • Navigate life post-treatment